4 May 2016 07:01
4 MAY 2016 |
ANNUAL REPORT AND ACCOUNTS
NOTICE OF ANNUAL GENERAL MEETING: 26 MAY 2016
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2015 has been posted to shareholders.
The Annual Report will be available later today, in electronic form, for download on the Company's website www.immupharma.org.
The Company's Annual General Meeting will be held on Thursday 26 May 2016 at 10:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.
-Ends-
| |||||||||||||
Immupharma (IMM)